ArticleFrontiers in immunology2022

Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer.

Lincheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.